- -

Optimizing strategies for meningococcal C disease vaccination in Valencia (Spain)

RiuNet: Repositorio Institucional de la Universidad Politécnica de Valencia

Compartir/Enviar a

Citas

Estadísticas

Optimizing strategies for meningococcal C disease vaccination in Valencia (Spain)

Mostrar el registro completo del ítem

Pérez Breva, L.; Villanueva Micó, RJ.; Villanueva-Oller, J.; Acedo Rodríguez, L.; Santonja, F.; Moraño Fernández, JA.; Abad, R.... (2014). Optimizing strategies for meningococcal C disease vaccination in Valencia (Spain). BMC Infectious Diseases. 14(280):1-7. doi:10.1186/1471-2334-14-280

Por favor, use este identificador para citar o enlazar este ítem: http://hdl.handle.net/10251/62462

Ficheros en el ítem

Metadatos del ítem

Título: Optimizing strategies for meningococcal C disease vaccination in Valencia (Spain)
Autor:
Entidad UPV: Universitat Politècnica de València. Departamento de Matemática Aplicada - Departament de Matemàtica Aplicada
Fecha difusión:
Resumen:
Background: Meningococcal C (MenC) conjugate vaccines have controlled invasive diseases associated with this serogroup in countries where they are included in National Immunization Programs and also in an extensive catch-up ...[+]
Palabras clave: Meningococcal C conjugate vaccines , Seroprotection study , Agent-based modelling , Vaccination programs
Derechos de uso: Reconocimiento (by)
Fuente:
BMC Infectious Diseases. (issn: 1471-2334 )
DOI: 10.1186/1471-2334-14-280
Editorial:
BioMed Central
Versión del editor: http://dx.doi.org/10.1186/1471-2334-14-280
Descripción: © 2014 Pérez-Breva et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Agradecimientos:
This paper has been supported by grant FIS PI-10/01433 from the Instituto de Salud Carlos III, and grant PAID-06-11 ref: 2087 from the Universitat Politecnica de Valencia. An agreement between CSISP-FISABIO and Baxter ...[+]
Tipo: Artículo

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro completo del ítem